BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 38499045)

  • 1. Minimally invasive surgery in the management of early stage cervical cancer after the publication of SHAPE trial.
    Nistor SI; El Tawab S; Zouridis A; Ferrari F; Soleymani Majd H
    Int J Gynecol Cancer; 2024 May; ():. PubMed ID: 38821544
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer.
    Bogani G; Di Donato V; Muzii L; Casarin J; Ghezzi F; Malzoni M; Greggi S; Landoni F; Bazzurini L; Zanagnolo V; Multinu F; Angioli R; Plotti F; Caruso G; Fischetti M; Ferrandina G; Palaia I; Benedetti Panici P; Scambia G; Raspagliesi F
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():64-69. PubMed ID: 35753229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.
    Takekuma M
    J Gynecol Oncol; 2024 Mar; 35(2):e48. PubMed ID: 38499045
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review.
    Fusegi A; Kanao H; Tsumura S; Murakami A; Abe A; Aoki Y; Nomura H
    J Gynecol Oncol; 2023 Jan; 34(1):e5. PubMed ID: 36424702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
    Frumovitz M; Obermair A; Coleman RL; Pareja R; Lopez A; Ribero R; Isla D; Rendon G; Bernardini MQ; Buda A; Moretti-Marquez R; Zevallos A; Vieira MA; Zhu T; Land RP; Nicklin J; Asher R; Robledo KP; Gebski V; Ramirez PT
    Lancet Oncol; 2020 Jun; 21(6):851-860. PubMed ID: 32502445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal cervical tumor-concealing no-look no-touch technique in minimally invasive radical hysterectomy for early-stage cervical cancer: a novel operation technique.
    Kanao H; Fusegi A; Omi M; Youssefzadeh AC; Nomura H; Matsuo K
    J Gynecol Oncol; 2023 May; 34(3):e27. PubMed ID: 36562133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
    Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
    Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
    Plante M; Kwon JS; Ferguson S; Samouëlian V; Ferron G; Maulard A; de Kroon C; Van Driel W; Tidy J; Williamson K; Mahner S; Kommoss S; Goffin F; Tamussino K; Eyjólfsdóttir B; Kim JW; Gleeson N; Brotto L; Tu D; Shepherd LE; ;
    N Engl J Med; 2024 Feb; 390(9):819-829. PubMed ID: 38416430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Cibula D; Raspollini MR; Planchamp F; Centeno C; Chargari C; Felix A; Fischerová D; Jahnn-Kuch D; Joly F; Kohler C; Lax S; Lorusso D; Mahantshetty U; Mathevet P; Naik R; Nout RA; Oaknin A; Peccatori F; Persson J; Querleu D; Bernabé SR; Schmid MP; Stepanyan A; Svintsitskyi V; Tamussino K; Zapardiel I; Lindegaard J
    Int J Gynecol Cancer; 2023 May; 33(5):649-666. PubMed ID: 37127326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IARC Perspective on Cervical Cancer Screening.
    Bouvard V; Wentzensen N; Mackie A; Berkhof J; Brotherton J; Giorgi-Rossi P; Kupets R; Smith R; Arrossi S; Bendahhou K; Canfell K; Chirenje ZM; Chung MH; Del Pino M; de Sanjosé S; Elfström M; Franco EL; Hamashima C; Hamers FF; Herrington CS; Murillo R; Sangrajrang S; Sankaranarayanan R; Saraiya M; Schiffman M; Zhao F; Arbyn M; Prendiville W; Indave Ruiz BI; Mosquera-Metcalfe I; Lauby-Secretan B
    N Engl J Med; 2021 Nov; 385(20):1908-1918. PubMed ID: 34758259
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.
    Tewari KS; Monk BJ
    J Clin Oncol; 2019 Sep; 37(27):2472-2489. PubMed ID: 31403858
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
    Ramirez PT; Frumovitz M; Pareja R; Lopez A; Vieira M; Ribeiro R; Buda A; Yan X; Shuzhong Y; Chetty N; Isla D; Tamura M; Zhu T; Robledo KP; Gebski V; Asher R; Behan V; Nicklin JL; Coleman RL; Obermair A
    N Engl J Med; 2018 Nov; 379(20):1895-1904. PubMed ID: 30380365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).
    Kunieda F; Kasamatsu T; Arimoto T; Onda T; Toita T; Shibata T; Fukuda H; Kamura T;
    Jpn J Clin Oncol; 2015 Jan; 45(1):123-6. PubMed ID: 25368103
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.